We are live on ! Find out more
PCC

Park Circle Company Portfolio holdings

AUM $108M
1-Year Est. Return 15.4%
This Fund
S&P 500
This Quarter Est. Return
+11.58%
1 Year Est. Return
+15.4%
3 Year Est. Return
+58.12%
5 Year Est. Return
+71.13%
10 Year Est. Return
+224%
AUM
$114M
AUM Growth
+$9.39M
Cap. Flow
-$1.36M
Cap. Flow %
-1.2%
Top 10 Hldgs %
56.33%
Holding
115
New
2
Increased
5
Reduced
4
Closed
8

Top Buys

Rank Stock Value
1
KSS icon
Kohl's
KSS
+$1.53M
2
BMY icon
Bristol-Myers Squibb
BMY
+$549K
3
ADT icon
ADT
ADT
+$495K
4
PBI icon
Pitney Bowes
PBI
+$405K
5
SRPT icon
Sarepta Therapeutics
SRPT
+$256K

Top Sells

Rank Stock Value
1
PSX icon
Phillips 66
PSX
+$847K
2
AIRC
Apartment Income REIT Corp.
AIRC
+$631K
3
XOM icon
ExxonMobil
XOM
+$504K
4
ECL icon
Ecolab
ECL
+$476K
5
MTB icon
M&T Bank
MTB
+$249K

Sector Composition

Rank Sector Weight
1 Financials 39.3%
2 Healthcare 15.26%
3 Consumer Discretionary 10.03%
4 Consumer Staples 7.94%
5 Technology 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WOLF icon
101
Wolfspeed
WOLF
$1.3B
$5.33K ﹤0.01%
550
+300
+120% +$4.42K
QRVO icon
102
Qorvo
QRVO
$7.85B
$5.17K ﹤0.01%
50
ANIX icon
103
Anixa Biosciences
ANIX
$119M
$1.57K ﹤0.01%
500
SLVM icon
104
Sylvamo
SLVM
$1.5B
$1.54K ﹤0.01%
18
DM
105
DELISTED
Desktop Metal, Inc.
DM
$934 ﹤0.01%
200
ECL icon
106
Ecolab
ECL
$77.8B
-2,000
Closed -$476K
KMX icon
107
CALL
CarMax
KMX
$8.25B
-2,000
Closed -$147K
PBI icon
108
CALL
Pitney Bowes
PBI
$2.48B
-125,000
Closed -$635K
PBI icon
109
PUT
Pitney Bowes
PBI
$2.48B
-125,000
Closed -$635K
PSX icon
110
Phillips 66
PSX
$84.4B
-6,000
Closed -$847K
TMO icon
111
Thermo Fisher Scientific
TMO
$213B
-75
Closed -$41.5K
WST icon
112
West Pharmaceutical
WST
$24.5B
-685
Closed -$226K
AIRC
113
DELISTED
Apartment Income REIT Corp.
AIRC
-16,152
Closed -$631K

Similar funds

Park Circle Company's Q3 2024 Portfolio in Review

As of Q3 2024, Park Circle Company held 115 positions worth $114M, up 9% from $105M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Park Circle Company's Q3 2024 filing shows 2 new, 5 increased, 4 reduced and 8 closed positions. Its largest new stake was Bristol-Myers Squibb: 11,700 shares worth $605K. The largest sale was Phillips 66, an estimated $847K.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 39% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Park Circle Company's largest Q3 2024 buy was Bristol-Myers Squibb: 11,700 shares worth $605K.
  • Park Circle Company added most to Kohl's in Q3 2024, an estimated $1.53M increase.
  • Park Circle Company's biggest Q3 2024 reduction was ExxonMobil, cutting an estimated $504K.
  • Park Circle Company fully exited Phillips 66 in Q3 2024, selling an estimated $847K.
  • Park Circle Company's ten largest holdings make up 56% of its $114M portfolio in Q3 2024.
  • Park Circle Company opened 2 new positions and closed 8 in Q3 2024.
  • Park Circle Company's portfolio value rose 9% quarter-over-quarter to $114M.

Based on Park Circle Company's 13F filing for Q3 2024, filed 8 Nov 2024.